| id | Study | Lib. in paper | Exposition period | Study type  | 
                Control type  | 
                Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S9114 R31315  | 
                Miškov (Phenobarbital) (Controls exposed to Lamotrigine, sick), 2016 | Medically induced abortion | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No | 
                    14.60 [0.24;902.47] C  excluded (control group)  | 
                
                0/3 0/37 | 0 | 3 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9115 R31319  | 
                Miškov (Phenobarbital) (Controls unexposed, disease free), 2016 | Medically induced abortion | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No | 
                    51.00 [0.83;3123.84] C  excluded (control group)  | 
                
                0/3 0/128 | 0 | 3 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9116 R31323  | 
                Miškov (Phenobarbital) (Controls unexposed, sick), 2016 | Medically induced abortion | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 1.40 [0.02;97.44] C | 0/3 0/4 | 0 | 3 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1 studies | 1.40 [0.02;97.44] | 0 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Phenobarbital) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 9114, 9115